TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
INVA

Innoviva Inc

Healthcare · Biotechnology

21.10$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Innoviva Inc (INVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 120 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement INVA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
67 86 77 103 90 92 89 100 108 118 98 120 443
10 13 11 18 10.0 7.2 8.8 11 26 42 22 29 119
57 73 67 85 80 85 80 90 82 76 76 91 324
4.0 2.4 3.9 2.6 3.6 3.7 4.4 8.0 14 4.6 5.2 5.2 29
29 26 30 28 26 31 27 26 27 32 32 35 126
33 35 41 30 30 42 121 138 47 37 38 40 162
24 38 26 55 50 43 -41 -49 35 39 38 51 163
4.4 6.0 5.9 5.8 5.8 4.7 4.7 4.7 4.0 3.3 5.4 5.5 18
86 61 45 -39 6.8 25 -39 73 98 195 235 -108 419
3.9 -0.3 8.6 -4.6 5.6 4.4 8.0 8.9 7.9 31 48 -25 62
82 62 37 -35 1.2 20 -47 64 90 164 187 -83 357
24 74 57 -24 19 36 -27 84 108 208 239 267 823

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?